文献速递头颈部肿瘤放疗放疗物理与技术

碳离子放疗头颈腺癌的多中心研究

A Multicenter Study of Carbon-Ion Radiation Therapy for Head and Neck Adenocarcinoma.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-05-03

日本多中心回顾性分析47例N0M0或N1M0头颈腺癌患者接受碳离子放疗的疗效与安全性,中位随访51个月,2年和5年总生存率分别为87.9%和60.4%,局部控制率分别为83.3%和79.3%,未观察到5级晚期毒性,4级晚期毒性均为视力损伤。

要点

  • 碳离子放疗对头颈腺癌局部控制良好,5年局部控制率79.3%。
  • 可手术和16次分割是总生存的独立预后因素。
  • 4级晚期毒性均为视力损伤,见于T4鼻咽或鼻窦肿瘤。

核心结论

  • 碳离子放疗对头颈腺癌局部控制优异,可作为可接受毒性的根治性治疗选择。

主要发现

  • 中位随访51个月,2年和5年总生存率分别为87.9%和60.4%。
  • 2年和5年局部控制率分别为83.3%和79.3%。
  • 多因素分析显示可手术(P=.045)和16次分割(P=.010)是总生存的独立预后因素。
  • 未观察到5级晚期毒性,4级晚期毒性4例均为视力损伤。

关键数值与推荐

  • 中位总剂量64.0 Gy(相对生物效应)分16次。

临床怎么用

  • 碳离子放疗可作为头颈腺癌的根治性治疗选项,尤其对不可手术患者需关注视力损伤风险。

局限性

  • 回顾性研究,样本量有限,随访时间范围较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Head and neck (HN) adenocarcinoma is rare, and to date, there have been no reports of prospective studies. We retrospectively evaluated the efficacy and safety of carbon-ion radiation therapy (C-ion RT) for HN adenocarcinoma in institutions in Japan. METHODS AND MATERIALS: HN adenocarcinoma patients with N0M0 or N1M0 disease who were treated with C-ion RT at institutions in Japan between November 2003 and December 2014 were analyzed retrospectively. We enrolled 47 patients (30 male and 17 female patients; median age, 60 years) with HN adenocarcinoma. RESULTS: Primary sites included the nasal and paranasal sinus in 21 patients, orbit in 11, salivary grand in 7, oral cavity and pharynx in 6, and acoustic organ in 2. Thirty-two patients had T4 tumors, 6 had T3, and 6 had T2. Forty-five patients received a diagnosis of N0 disease, whereas 2 had N1 disease. The median total dose of C-ion RT and the number of fractions were 64.0 Gy (relative biological effectiveness) and 16 fractions, respectively. The median follow-up period was 51 months (range, 6-118 months). The 2- and 5-year overall survival rates were 87.9% and 60.4%, respectively, and the 2- and 5-year local control rates were 83.3% and 79.3%, respectively. Multivariate analysis showed that operability (patients with operable tumors) (P=.045) and fractionation (16 fractions) (P=.010) were significant independent prognostic factors for better overall survival. No grade 5 late morbidities were observed. Grade 4 late morbidities were observed in 4 patients, and all of these grade 4 morbidities were visual impairments. All 4 patients with grade 4 visual impairment had T4 tumors in the nasopharynx or paranasal sinuses, which implied inoperable tumors with orbital or brain invasion. CONCLUSIONS: C-ion RT resulted in excellent local control. C-ion RT could become a curative treatment option for HN adenocarcinoma with acceptable toxicities.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Saitoh JI, Koto M, Demizu Y, et al. A Multicenter Study of Carbon-Ion Radiation Therapy for Head and Neck Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2017. PMID: 28871995. doi:10.1016/j.ijrobp.2017.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。